PolyBio
@polybioRF
501(c)3 transforming how #LongCovid, #ME/CFS & Lyme+ are studied, diagnosed, and treated. Leading the #LongCovid Research Consortium.
PolyBio Research Foundation is excited to be leading the #LongCovid Research Consortium: a scientific collaboration between top global research teams to rapidly & comprensively study LongCovid, with a focus on the topic of SARS-CoV-2 persistence in tissue: polybio.org/longcovid
PolyBio brings together researchers from across the science and health fields—from experts on the microbiome, to those on the female reproductive tract—to collaborate in advancing our understanding of pathogens & their impact on the human body. At PolyBio, every day is a step…
PolyBio President Dr. Amy Proal is excited for Dr. Akiko Iwasaki to join SPEAR—a study group at @Invivyd that aims to assess Mab therapies for Long Covid and COVID-19 post-vaccination syndrome. Current members of the team include Dr. Proal, as well as Dr. David Putrino & Dr.…
V. excited to join the SPEAR (Spike Protein Elimination and Recovery) team with @MichaelPelusoMD @microbeminded2 @PutrinoLab @Invivyd to study whether broadly neutralizing mAb can treat Long COVID and post-vaccination syndrome subset driven by persistent spike protein.…
V. excited to join the SPEAR (Spike Protein Elimination and Recovery) team with @MichaelPelusoMD @microbeminded2 @PutrinoLab @Invivyd to study whether broadly neutralizing mAb can treat Long COVID and post-vaccination syndrome subset driven by persistent spike protein.…